Akèy › Lukemi lenfositè kwonik › Kalifòni › San Francisco

Etid klinik pou Lukemi lenfositè kwonik nan San Francisco, CA

4 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Ap rekriteFaz 3

Kaiser Permanente San Francisco Medical Center Oncology, San Francisco

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06973187

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1

University of California, San Francisco, San Francisco

Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Ap rekriteFaz 1

University of California, San Francisco, San Francisco

Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT04545762

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Ap rekriteFaz 2

San Francisco VA Medical Center, San Francisco, CA, San Francisco

Laj 18 a 80 · Tout sèks · Mizajou Oct 14, 2025 · NCT06520098

Etid Lukemi lenfositè kwonik nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.